CG
INFI

Cutler Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Cutler Group’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,800
Closed -$1K – 6382
2021
Q3 		$1K Buy
+9,800
New +$30.2K ﹤0.01% 5537

Other funds holding INFI

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Cutler Group's INFI Position: Q3 2023 in Review

Cutler Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 200 shares.

Cutler Group first reported a position in INFI in Q4 2015 and held it in 14 quarters. The position peaked at $20K in Q4 2021. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

  • Cutler Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 200 Infinity Pharmaceuticals, Inc. shares in Q3 2023.
  • Cutler Group first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2015 and held it in 14 quarters.
  • Cutler Group's Infinity Pharmaceuticals, Inc. position peaked at $20K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.